Jinrong Liu

Title: Jinrong Liu: Innovator in Uric Acid Management

Introduction

Jinrong Liu is a notable inventor based in Jinan, China. He has made significant contributions to the field of medicine, particularly in the prevention and treatment of uratic or gouty diseases. His innovative approach has led to the development of a unique pharmaceutical compound aimed at reducing uric acid levels and alleviating related health issues.

Latest Patents

Jinrong Liu holds 1 patent for his invention titled "Prevention or treatment of uratic or gouty diseases." This patent describes the use of a compound of formula (I), along with its pharmaceutically acceptable salts and solvates, in reducing uric acid levels. The invention focuses on preventing or treating hyperuricemia, gout, gouty inflammations, pain, and uric acid nephropathy. This groundbreaking work has the potential to improve the quality of life for individuals suffering from these conditions.

Career Highlights

Throughout his career, Jinrong Liu has worked with reputable companies such as Shanton Pharma Co., Ltd and Shanton Pharma Pte. Ltd. His experience in these organizations has allowed him to refine his skills and contribute to the advancement of pharmaceutical innovations.

Collaborations

Jinrong Liu has collaborated with esteemed colleagues, including Qian Zhang and Zhenhua Huang. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.

Conclusion

Jinrong Liu's contributions to the field of medicine, particularly in the management of uratic and gouty diseases, highlight his innovative spirit and dedication to improving health outcomes. His work continues to inspire advancements in pharmaceutical science.